Avricore Health Inc. (AVCRF)
OTCMKTS · Delayed Price · Currency is USD
0.0424
0.00 (0.00%)
Jun 5, 2025, 8:00 PM EDT

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of 4.07 million. The enterprise value is 3.14 million.

Market Cap 4.07M
Enterprise Value 3.14M

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date May 29, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 101.29M
Shares Outstanding n/a
Shares Change (YoY) +1.03%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 90.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.43
PB Ratio 3.00
P/TBV Ratio 3.11
P/FCF Ratio 9.05
P/OCF Ratio 7.15
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.25, with an EV/FCF ratio of 6.97.

EV / Earnings -4.93
EV / Sales 1.05
EV / EBITDA 14.25
EV / EBIT n/a
EV / FCF 6.97

Financial Position

The company has a current ratio of 7.40

Current Ratio 7.40
Quick Ratio 7.10
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -43.85% and return on invested capital (ROIC) is -2.00%.

Return on Equity (ROE) -43.85%
Return on Assets (ROA) -1.69%
Return on Invested Capital (ROIC) -2.00%
Return on Capital Employed (ROCE) -3.43%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 1.66
Inventory Turnover 357.92

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.42% in the last 52 weeks. The beta is -1.61, so Avricore Health's price volatility has been lower than the market average.

Beta (5Y) -1.61
52-Week Price Change -67.42%
50-Day Moving Average 0.04
200-Day Moving Average 0.07
Relative Strength Index (RSI) 53.12
Average Volume (20 Days) 52,905

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Avricore Health had revenue of 2.85 million and -636,502 in losses. Loss per share was -0.01.

Revenue 2.85M
Gross Profit 1.21M
Operating Income -46,541
Pretax Income -636,502
Net Income -636,502
EBITDA 209,438
EBIT -46,541
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 890,322 in cash and n/a in debt, giving a net cash position of 890,322.

Cash & Cash Equivalents 890,322
Total Debt n/a
Net Cash 890,322
Net Cash Per Share n/a
Equity (Book Value) 1.36M
Book Value Per Share 0.01
Working Capital 832,744
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 569,101 and capital expenditures -119,172, giving a free cash flow of 449,929.

Operating Cash Flow 569,101
Capital Expenditures -119,172
Free Cash Flow 449,929
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 42.53%, with operating and profit margins of -1.63% and -22.34%.

Gross Margin 42.53%
Operating Margin -1.63%
Pretax Margin -22.34%
Profit Margin -22.34%
EBITDA Margin 7.35%
EBIT Margin -1.63%
FCF Margin 15.79%

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.03%
Shareholder Yield n/a
Earnings Yield -15.64%
FCF Yield 11.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date Nov 21, 2016
Split Type Reverse
Split Ratio 0.25

Scores

Avricore Health has an Altman Z-Score of 27.17.

Altman Z-Score 27.17
Piotroski F-Score n/a